Projects funded by the NCN
Anticancer activity mechanism and biotechnological obtaining of rinderol - a novel naphthoquinone derivative
2019/33/N/NZ7/01782
Keywords:
naphthoquinones anticancer activity apoptosis medicinal plant biotechnology in situ extraction biomass immobilization
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_3: Apoptosis
- NZ7_16: Other related subjects
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 17 - announced on 2019-03-15
Amount awarded: 209 999 PLN
Project start date (Y-m-d): 2020-03-05
Project end date (Y-m-d): 2023-03-04
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.